옵션 체인은 다양한 행사가격과 만기일에 대한 TEN Holdings의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 TEN Holdings에 대한 시장 심리를 평가합니다..

TEN Holdings (NASDAQ:XHLD) 주식, 옵션 체인

TEN Holdings Inc is a provider of event planning, production, and broadcasting services. It produce virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by its Xyvid Pro Platform. Physical events involve live streaming and video recording of physical events. The Company operates business as one operating segment which includes two revenue types: Hybrid and Virtual Events and Physical Events. Key revenue is generated from Virtual and Hybrid events.

TEN Holdings Inc

Biotech

General

CADL

Candel Therapeutics And IDEA Pharma Announce Commercial Partnership, IDEA To Provide Commercial Input Throughout Candel's Development And Commercialization Process For CAN-2409

Five Below, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) reported better-than-expected fourth-quarter financial results and <a href="https://www.benzinga.com/news/earnings/25/03/44406668/five-below-stock-moves-higher-on-q4-earnings-beat">issued first-quarter guidance above estimates on Wednesday.</a>
Five Below posted adjusted earnings of $3.48 per share, beating estimates of $3.38 per share. The company's sales came in at $1.391 billion versus expectations of $1.386 billion.
"It has been a busy three months at Five Below. We are executing our key strategies around product, value and store experience, and doing so with a sharpened focus on our core customer — the kid and the kid in all of us," said Winnie Park, CEO of Five Below.
Five Below expects first-quarter revenue to be in the range of $905 million to $925 million versus estimates of $898.08 million. The company anticipates first-quarter adjusted earnings of 50 to 61 cents per share versus estimates of 49 cents per share.
Five Below also provided guidance for the full year 2025. The company sees full-year revenue of $4.21 billion to $4.33 billion versus estimates of $4.27 billion. The company expects full-year adjusted earnings to be between $4.10 and $4.72 per share versus estimates of $5.06 per share.
Five Below shares gained 2.3% to close at $75.59 on Wednesday.
These analysts made changes to their price targets on Five Below following earnings announcement.
<ul>
<li>Morgan Stanley analyst Simeon Gutman maintained Five Below with an Equal-Weight rating and lowered the price target from $120 to $110.</li>
<li>B of A Securities analyst Melanie Nunez maintained the stock with an Underperform rating and lowered the price target from $88 to $75.</li>
</ul>
Considering buying FIVE stock? Here&#8217;s what analysts think: 
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer Says TJX Is &#8216;Terrific,&#8217; Recommends Buying These Stocks</a></li>
</ul>

Earnings

News

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

FIVE

These Analysts Slash Their Forecasts On Five Below After Q4 Results

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Capricor Therapeutics, revealing an average target of $77.0, a high estimate of $77.00, and a low estimate of $77.00. Staying constant with the previous average price target, the current average remains unchanged. 
<img src="https://www.benzinga.com/files/images/story/2025/1742472128_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Capricor Therapeutics is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$77.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$77.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$77.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$77.00</td>
<td>$77.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Capricor Therapeutics. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Capricor Therapeutics compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Capricor Therapeutics's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Capricor Therapeutics's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CAPR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Capricor Therapeutics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About Capricor Therapeutics</h2>
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
<h3>Capricor Therapeutics: A Financial Overview</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Negative Revenue Trend: Examining Capricor Therapeutics's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -63.44% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -555.2%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -31.48%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Capricor Therapeutics's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -19.14%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.02.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAPR

A Glimpse Into The Expert Outlook On Capricor Therapeutics Through 4 Analysts

Keybanc analyst Noah Zatzkin downgrades Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) from Sector Weight to Underweight and announces $65 price target.

Downgrades

Keybanc Downgrades Thor Industries to Underweight, Announces $65 Price Target

During the last three months, 7 analysts shared their evaluations of TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $149.43, along with a high estimate of $165.00 and a low estimate of $140.00. This upward trend is apparent, with the current average reflecting a 10.45% increase from the previous average price target of $135.29.
<img src="https://www.benzinga.com/files/images/story/2025/1742472109_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of TD Synnex's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vincent Colicchio</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$156.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Joseph Cardoso</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$148.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Shreya Gheewala</td>
<td>CFRA</td>
<td>Raises</td>
<td>Buy</td>
<td>$147.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$140.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to TD Synnex. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of TD Synnex compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for TD Synnex's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into TD Synnex's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SNX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on TD Synnex analyst ratings.</a>
<h2>Delving into TD Synnex's Background</h2>
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
<h3>Financial Insights: TD Synnex</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: TD Synnex displayed positive results in 3 months. As of 30 November, 2024, the company achieved a solid revenue growth rate of approximately 9.98%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: TD Synnex's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 1.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.38%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): TD Synnex's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.65%, the company may face hurdles in achieving optimal financial returns.
Debt Management: TD Synnex's debt-to-equity ratio is below the industry average at 0.49, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying TD Synnex: Insights From 7 Analyst Reviews

Although few would doubt the genius of Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk, even the<a href="https://www.benzinga.com/startups/25/01/43101102/elon-musk-the-richest-man-in-the-world-is-estimated-to-earn-over-23-million-every-single-hour-of-the-day-heres-how-hes-spending-it"> world's richest man</a> is not immune to severe – and potentially crippling – criticism. Due to<a href="https://www.benzinga.com/news/25/03/44209579/unprecedented-slide-tesla-sales-plummet-45-in-europe-as-musks-net-worth-dives-5-2b-in-a-week"> significant headwinds impacting the electric vehicle manufacturer</a>, Musk's net worth suffered a sizable erosion. As such, the volatility in TSLA stock has raised serious questions about the underlying company's path forward.
Worryingly, in the European market,<a href="https://www.bloomberg.com/news/articles/2025-02-25/tesla-sales-fall-45-in-europe-as-rivals-ev-registrations-soar?embedded-checkout=true"> Tesla's sales shockingly plunged 45% in January</a>. Even more conspicuous, during the same period, the region's market for all EVs expanded by 37%. To be sure, a good deal of the performance drag can be attributed to intense competition from Chinese automakers, along with slowing consumer demand.
However, it's also fair to point out that Tesla's head executive incurred unforced and unnecessary errors. As several news publications reported earlier this year, Musk's social media posts have<a href="https://www.benzinga.com/tech/25/02/43770024/from-tech-to-politics-how-elon-musk-is-empowering-far-right-across-the-globe"> lent support to right-wing protests and advocacy movements</a>. Furthermore, his close ties with President Donald Trump have made<a href="https://www.benzinga.com/news/25/03/44348055/anti-musk-protester-vandalizes-tesla-cybertruck-with-swastika-shocking-jewish-owner"> Tesla EVs a target for vandalism</a>.
In an effort to shift the tide, President Trump<a href="https://www.benzinga.com/markets/25/03/44346155/trumps-tesla-shoutout-falls-flat-no-spike-in-orders-or-inventory-movement"> initiated a publicity stunt</a> for Tesla in front of the White House recently. However, sales and inventory data revealed that the event had a minimal impact on the company's top line, potentially demonstrating the general distaste consumers have for the EV brand right now.
At the same time, not everyone agrees with the doom-and-gloom narrative. RBC Capital analyst Tom Narayan maintained an Outperform rating on TSLA stock, stating a belief that<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44380301/tesla-analyst-says-demand-fears-overblown-but-has-some-concerns-as-used-car-prices-plummet"> demand fears are likely overblown</a>. While the expert does cite concerns about used car prices for certain Tesla models, the decline in Europe and China might not be terribly significant. These markets in Narayan's view represent a small portion of Tesla's overall sales.
In addition, Cantor Fitzgerald analyst Andres Sheppard<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44399812/tesla-analyst-turns-bullish-following-factory-visit-sees-multiple-catalysts-driving-ev-stock-to-425"> lifted TSLA stock to Overweight from Neutral</a>, while maintaining a $425 price target. This assessment followed the expert visiting the EV manufacturer's Austin Gigafactory and artificial intelligence data centers. With potentially strong fundamentals, compelling strategic initiatives and a discounted valuation, TSLA may offer upside potential.
The Direxion ETFs: With TSLA stock liable to go in either direction, this potential dynamism enables speculative trading activity. For the optimists, they may consider the Direxion Daily TSLA Bull 2X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLL#NASDAQ">TSLL</a>). On the other hand, those who remain skeptical may be interested in the Direxion Daily TSLA Bear 1X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLS#NASDAQ">TSLS</a>).
Primarily, both ETFs offer a convenient mechanism to enjoy leverage or trades that follow bearish strategies without resorting to the complex nuances of options. According to Direxion's website, the TSLL tracks the daily investment results of 200% of TSLA stock. The TSLS, in contrast, tracks 100% of the inverse performance of TSLA.
However, prospective participants should note that exposure to these specialized exchange-traded funds is meant to last for no longer than one day. Any longer and the ETF cannot guarantee that the performance will track with the underlying security due to the daily compounding effect.
The TSLL ETF: Although one of the best performers last year, the TSLL ETF is down more than 70% this year, a sobering statistic.
<ul>
<li>Unsurprisingly, the Tesla 2X bull fund sits well below its 50-day and 200-day moving averages (DMA). Without additional support, the leveraged ETF could soon print the dreaded death cross.</li>
<li>It's possible that the bulls are attempting to build a baseline here, which aligns with long-term support. However, the bulls need to start moving in quickly before more technical damage occurs.</li>
</ul>
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXeWeO-KX4PyunqMOVk7id6QwFQnC5FM-_8MhSuqKQUVBAoIiThP39fGJfL8fPVsUqooViQD2cnJ6a6yJJyup97awTCxVsYBaTTeKZ8jTi69d1SKYppy-Y7ejWdl1k9Bo1eYFPOREA?key=ChoEIQj_by4_ogZMvVkTUzPa" alt="" /></figure>
The TSLS ETF: Representing a reversal of fortune, the TSLS ETF is currently flying, gaining speculators over 57% since the start of the year.
<ul>
<li>The TSLA bear fund shot above its 50 DMA in early February and is now attempting to break above its 200 DMA.</li>
<li>It appears that the bears are taking a breather before amassing an attack on the $15 level. If that resistance point breaks, speculators will next set their sights on $20.</li>
</ul>
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcSz18knNYTCkTqVXE-hnr-o1qkv73Gi0LPy0USoK9k62oQlpp338GbgAWgqQmY-kSAh9mr2Ri9gR5iiSrcqrpqQL9FqbQHrN_gyFCNKIx2z3RSApMm1oeKN7KbQsNvDh7BhGC0TA?key=ChoEIQj_by4_ogZMvVkTUzPa" alt="" /></figure>
Featured photo by <a href="https://pixabay.com/users/volzi-11716582/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=8063158">Andreas Volz</a> on <a href="https://pixabay.com/illustrations/car-tesla-windmills-vehicle-auto-8063158/">Pixabay</a>.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.&nbsp;

Long Ideas

Short Ideas

Technicals

ETFs

TSLA

TSLL

TSLS

Clashing Opinions Deliver Ample Trading Grounds For Direxion's TSLA Bull And Bear ETFs

BlackBerry's QNX And Advantech Expand Collaboration To Better Serve Joint-customers Across Embedded Systems Industry

Throughout the last three months, 16 analysts have evaluated Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $1072.19, a high estimate of $1135.00, and a low estimate of $980.00. Observing a 1.93% increase, the current average has risen from the previous average price target of $1051.88. 
<img src="https://www.benzinga.com/files/images/story/2025/1742472084_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Costco Wholesale. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$1035.00</td>
<td>$1075.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1070.00</td>
<td>$1050.00</td>
</tr>
<tr>
<td>Karen Short</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$980.00</td>
<td>$940.00</td>
</tr>
<tr>
<td>Laura Champine</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$1135.00</td>
<td>$1150.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$995.00</td>
<td>$935.00</td>
</tr>
<tr>
<td>Christopher Horvers</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1070.00</td>
<td>$1065.00</td>
</tr>
<tr>
<td>Peter Benedict</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1125.00</td>
<td>$1075.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Michael Baker</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$1000.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$1075.00</td>
<td>$1000.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1070.00</td>
<td>$1040.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Costco Wholesale. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Costco Wholesale compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Costco Wholesale's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Costco Wholesale's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/COST/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Costco Wholesale analyst ratings.</a>
<h2>Unveiling the Story Behind Costco Wholesale</h2>
Costco operates a membership-based, no-frills retail model predicated on offering a select product assortment in bulk quantities at bargain prices. The firm avoids maintaining costly product displays by keeping inventory on pallets and limits distribution expenses by storing its inventory at point of sale in the warehouse. Given its frugal cost structure, the firm is able to price its merchandise below that of competing retailers, driving high sales volume per warehouse and generating strong profits on thin margins. Costco operates over 600 warehouses in the United States and has over 60% share in the domestic warehouse club industry. Internationally, Costco operates another 280 warehouses, primarily in Canada, Mexico, Japan, and the UK.
<h3>Financial Insights: Costco Wholesale</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Costco Wholesale's remarkable performance in 3 months is evident. As of 28 February, 2025, the company achieved an impressive revenue growth rate of 9.04%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Costco Wholesale's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.81% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Costco Wholesale's ROE excels beyond industry benchmarks, reaching 7.15%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Costco Wholesale's ROA excels beyond industry benchmarks, reaching 2.44%. This signifies efficient management of assets and strong financial health.
Debt Management: Costco Wholesale's debt-to-equity ratio is below the industry average at 0.31, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COST

Demystifying Costco Wholesale: Insights From 16 Analyst Reviews

22 analysts have shared their evaluations of Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $137.82, a high estimate of $155.00, and a low estimate of $120.00. This current average represents a 5.16% decrease from the previous average price target of $145.32. 
<img src="https://www.benzinga.com/files/images/story/2025/1742472071_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Target. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$120.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Rupesh Parikh</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$155.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Robert Ohmes</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$145.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$124.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$142.00</td>
<td>$166.00</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$122.00</td>
<td>$131.00</td>
</tr>
<tr>
<td>Michael Baker</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$140.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$124.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$130.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$130.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Christopher Horvers</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$146.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$145.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Corey Tarlowe</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$150.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Christopher Horvers</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$146.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Zhihan Ma</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$142.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Robert Drbul</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$155.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$133.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$134.00</td>
<td>$129.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$150.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Target. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Target compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Target's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Target's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/TGT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Target analyst ratings.</a>
<h2>About Target</h2>
Target serves as the nation's seventh-largest retailer, with its strategy predicated on delivering a gratifying in-store shopping experience and a wide product assortment of trendy apparel, home goods, and household essentials at competitive prices. Target's upscale and stylish image began to carry national merit in the 1990s—a decade in which the brand saw its top line grow threefold to almost $30 billion—and has since cemented itself as a leading US retailer.Today, Target operates over 1,900 stores in the United States, generates over $100 billion in sales, and fulfills over 2 billion customer orders annually. The firm's vast footprint is typically concentrated in urban and suburban markets as the firm seeks to attract a more affluent consumer base.
<h3>A Deep Dive into Target's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining Target's financials over 3 months reveals challenges. As of 31 January, 2025, the company experienced a decline of approximately -3.15% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Target's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.57% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Target's ROE excels beyond industry benchmarks, reaching 7.57%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Target's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.9% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Target's debt-to-equity ratio surpasses industry norms, standing at 1.36. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Target Through The Eyes Of 22 Analysts

Ratings for Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) were provided by 24 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">17</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Walmart and provided 12-month price targets. The average target is $108.67, accompanied by a high estimate of $120.00 and a low estimate of $93.00. Surpassing the previous average price target of $101.83, the current average has increased by 6.72%.
<img src="https://www.benzinga.com/files/images/story/2025/1742472046_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Walmart. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$93.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Robert Drbul</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$107.00</td>
<td>$109.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$112.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$108.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>John Vinh</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$114.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$118.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Peter Benedict</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Seth Sigman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$108.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$115.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$111.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$120.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Christopher Horvers</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$112.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Rupesh Parikh</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$108.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$113.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$106.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Seth Sigman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$98.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Walmart. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Walmart compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Walmart's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Walmart's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WMT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Walmart analyst ratings.</a>
<h2>About Walmart</h2>
Walmart serves as the preeminent retailer in the United States, with its strategy predicated on superior operating efficiency and offering the lowest priced goods to consumers to drive robust store traffic and product turnover. Walmart augmented its low-price business strategy by offering a convenient one-stop shopping destination with the opening of its first supercenter in 1988.Today, Walmart operates over 4,600 stores in the United States (5,200 including Sam's Club) and over 10,000 locations globally. Walmart generated over $440 billion in domestic namesake sales in fiscal 2024, with Sam's Club contributing another $86 billion to the company's top line. Internationally, Walmart generated $115 billion in sales. The retailer serves around 240 million customers globally each week.
<h3>Walmart: Delving into Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining Walmart's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.13% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Walmart's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 2.91%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Walmart's ROE excels beyond industry benchmarks, reaching 5.87%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Walmart's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.0% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.66.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Walmart Stock

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Vertex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERX#NASDAQ">VERX</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Vertex, presenting an average target of $49.86, a high estimate of $62.00, and a low estimate of $31.00. A decline of 18.7% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1742472034_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive Vertex is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Adam Hotchkiss</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$48.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$48.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>William Jellison</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Rob Oliver</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$31.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>William Jellison</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Buy</td>
<td>$62.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Vertex. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Vertex compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Vertex's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VERX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Vertex analyst ratings.</a>
<h2>About Vertex</h2>
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.
<h3>Vertex: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Vertex showcased positive performance, achieving a revenue growth rate of 15.2% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Vertex's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -37.99%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Vertex's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -30.93%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Vertex's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -5.75%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Vertex's debt-to-equity ratio surpasses industry norms, standing at 1.96. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VERX

Deep Dive Into Vertex Stock: Analyst Perspectives (7 Ratings)

This agreement aims to ensure strict adherence to environmental regulations throughout the site investigation process and reinforces Oklo's commitment to environmental stewardship throughout the project.

OKLO

Oklo Enters Interface Agreement With Idaho National Laboratory

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said he likes Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) and recommended buying the stock under $120 per share. &#8220;Next buy, 100. Get a <a href="https://www.benzinga.com/news/earnings/25/01/43356259/deckers-outdoor-shares-clobbered-despite-strong-q3-results-led-by-ugg-hoka-brands">good basis,&#8221; he added</a>.
On the earnings front, Deckers Outdoor, on Jan. 30, reported quarterly earnings of $3 per share which beat the analyst consensus estimate of $2.55 per share. 
Quarterly revenue came in at $1.83 billion which beat the analyst consensus estimate of $1.73 billion and is an increase over sales of $1.56 billion from the same period last year.
"Deckers posted exceptional results in the third quarter, delivering record quarterly revenue, gross margin, and earnings," said Stefano Caroti, CEO of Deckers Outdoor.
&#8220;I'm going to see your Gladstone Land (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAND#NASDAQ">LAND</a>) and raise you with Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>),&#8221; Cramer said.
On Feb. 19, Gladstone Land reported quarterly earnings of 9 cents per share which missed the analyst consensus estimate of 11 cents per share. 
The company reported quarterly sales of $21.10 million which beat the analyst consensus estimate of $20.45 million.
Price Action:
<ul>
<li>Deckers Outdoor shares gained 3.3% to settle at $119.05 on Wednesday.</li>
<li>Gladstone Land shares fell 0.6% to close at $10.70 during the session.</li>
<li>Realty Income shares fell 0.9% to settle at $56.44.</li>
</ul>
Read Next:<a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks"> </a>
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer Says TJX Is &#8216;Terrific,&#8217; Recommends Buying These Stocks</a></li>
</ul>
Image: Shutterstock

Media

DECK

LAND

Jim Cramer Recommends Deckers Outdoor, Realty Income: 'Get A Good Basis'

Offerings

Sunoco Plans Private Offering Of Senior Notes Due 2033 In An Aggregate Principal Amount Of $750M

Copper prices have surged above $10,000 per metric ton on the London Metal Exchange (LME) for the first time since October. On LME, copper has gained 14% year-to-date, while <a target="_blank" href="https://www.benzinga.com/topic/copper" rel="noreferrer noopener">U.S. copper futures</a> surged 26%.
The price differential widened to $1,200 per metric ton, creating arbitrage opportunities. Since copper futures result in physical delivery on maturity, buyers have scrambled to move supplies into the U.S.
Between 100,000 and 150,000 metric tons of copper will arrive in the U.S. in the coming weeks, potentially surpassing the monthly import record of 136,951 tons set in January 2022.
Leading commodity traders, including Trafigura, Glencore, and Gunvor, have aggressively rerouted shipments, with additional warehouse space being secured in New Orleans and Baltimore to handle the influx.
Still, the 12% differential between the domestic and foreign copper prices is around half of anticipated copper tariffs.
On February 25, President Donald Trump signed an executive action directing the U.S. Commerce Department to investigate copper imports on national security grounds. Leading institutions, including Goldman Sachs and Citigroup, responded, predicting a <a target="_blank" href="https://www.benzinga.com/news/guidance/25/03/44271394/goldman-sachs-sees-copper-imports-increasing-tariffs-as-fcx-positions-to-benefit" rel="noreferrer noopener">25% tariff</a> on imported copper by year-end.
"Copper's rise is being driven solely by supply concerns surrounding the potential for universal tariffs to be placed on all imports of copper into the US," Natalie Scott-Gray, a senior metals demand analyst at StoneX, <a target="_blank" href="https://x.com/neilksethi/status/1902053890079535258" rel="noreferrer noopener">said</a>, warning about the high reliance on foreign copper.
According to ING, in 2024, the U.S. imported <a target="_blank" href="https://think.ing.com/articles/industrial-metals-monthly-us-copper-tariff-risks-pull-more-metal-to-the-us/" rel="noreferrer noopener">850,000 tons</a> of refined copper, excluding scrap. Chile was the largest supplier, accounting for 41% of imports, while 27% came from Canada.
Despite efforts to increase local production, output has steadily declined, falling 3% in 2024 after an 11% drop in 2023. Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), the largest U.S. producer, has faced declining ore grades, environmental regulations, and permitting challenges, limiting the ability to ramp up domestic supply.
The firm's CEO, Kathleen Quirk, has called for Trump's administration to classify copper as a critical mineral, anticipating a $500 million windfall from tax credits tied to the Inflation Reduction Act. Quirk sees Freeport's domestic production growing by 8%, targeting an output of 225,000 metric tons, none of which will be exported.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44375055/trump-turns-to-beautiful-clean-coal-to-address-domestic-energy-demand" target="_blank" rel="noreferrer noopener">Trump Turns To ‘Beautiful, Clean Coal' To Address Domestic Energy Demand</a></li>
</ul>
Photo via Shutterstock

Government

Large Cap

Guidance

Commodities

Legal

COPX

CPER

FQVLF

JJCTF

LUNMF

MTAL

SCCO

Copper Surges As Arbitrage Opportunity Drives US Imports

Wedbush analyst Martin Fan initiates coverage on Zenas BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBIO#NASDAQ">ZBIO</a>) with a Outperform rating.

Initiation

ZBIO

Wedbush Initiates Coverage On Zenas BioPharma with Outperform Rating

Barrington Research analyst Vincent Colicchio maintains TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) with a Outperform and raises the price target from $138 to $156.

Barrington Research Maintains Outperform on TD Synnex, Raises Price Target to $156

WIIM

Jabil shares are trading higher after the company reported better-than-expected Q2 financial results.

Top Republican lawmakers overseeing the Pentagon have expressed concerns over reports of possible adjustments to U.S. military commands under the Trump administration.
What Happened: Sen. Roger Wicker (R-Miss.) and Rep. Mike Rogers (R-Ala.), the senior Republican lawmakers responsible for the Pentagon&#8217;s oversight committees, issued a joint statement expressing concern over reports that the Trump administration might relinquish the U.S. role as NATO&#8217;s Supreme Allied Commander Europe (SACEUR). The SACEUR role, responsible for overseeing all NATO operations in Europe, has been held by a four-star U.S. general since 1950, a command initiated by Dwight D. Eisenhower during World War II.
Despite sources indicating that such a move has been discussed, no official announcement has been made, and it may not be a feasible option. Wicker and Rogers declared &#8220;We will not accept significant changes to our warfighting structure that are made without a rigorous interagency process, coordination with combatant commanders and the Joint Staff, and collaboration with Congress.&#8221; 
They cautioned that such changes could potentially weaken American deterrence globally and undermine U.S. negotiation positions with adversaries.
SEE ALSO: <a href="https://www.benzinga.com/tech/25/03/44411032/mrbeasts-new-challenges-are-absolutely-unhinged-again-a-jet-a-jail-a-gym-and-1-5-million-on-the-line">MrBeast&#8217;s New Challenges Are Absolutely Unhinged (Again): A Jet, A Jail, A Gym—And $1.5 Million On The Line</a>
Why It Matters: Lawmakers reacted to an NBC <a href="https://www.nbcnews.com/politics/national-security/trump-admin-considers-giving-nato-command-exclusively-american-eisenho-rcna196503">News report</a> which first stated that the Trump administration may relinquish the role of NATO&#8217;s Supreme Allied Commander Europe, according to anonymous officials.
The potential reshuffling of military commands comes in the wake of President Donald Trump&#8216;s cost-cutting campaign targeting the Pentagon's $800 billion budget. In February, Trump backed <a href="https://www.benzinga.com/news/25/02/43752207/were-going-to-find-billions-trump-targets-pentagon-for-deep-spending-cuts">Elon Musk&#8217;s efforts</a> to uncover &#8220;billions, hundreds of billions of dollars of fraud and abuse&#8221; in the Defense Department spending. This move raised conflict-of-interest concerns due to Musk's SpaceX and Starlink contracts with the government. 
However, National Security Adviser Mike Waltz dismissed these concerns, assuring that &#8220;all of the appropriate firewalls&#8221; would be in place. The potential reshuffling of commands could be seen as a continuation of this cost-cutting initiative, but it remains to be seen how it will impact the U.S.&#8217;s relations with its NATO allies.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/news/mid-cap/25/03/44412592/alvotech-strengthens-biosimilar-portfolio-with-27-million-xbrane-rd-deal">Alvotech Strengthens Biosimilar Portfolio With $27 Million Xbrane R&amp;D Deal</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Top Republican Lawmakers Oppose Potential Pentagon Reshuffle Amid Reports: 'Such Moves Risk Undermining American Deterrence'

CELZ

Creative Medical Says FDA Cleared Expanded Dose Escalation For Phase 1/2 Trial Of StemSpine Using AlloStem For Chronic Lower Back Pain

Press Releases

TEN Holdings, Inc. Announces Pricing of $10.0 Million Initial Public Offering

TEN Holdings, Inc. Announces Closing of Initial Public Offering

Entertainment

TEN Holdings, Inc. Announces $1 Million Stock Repurchase Program

XHLD

Able View Global Inc. - Class B Ordinary Shares

Able View Global

Amber International Holding Limited - American Depositary Shares

Amber International

AirNet Technology Inc. - American Depositary Shares, each representing one ordinary shares

Comments

TEN Holdings

TEN Holdings (XHLD) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌